{"id":6289,"date":"2026-02-26T17:51:22","date_gmt":"2026-02-26T20:51:22","guid":{"rendered":"https:\/\/confrapar.com.br\/en\/?p=6289"},"modified":"2026-02-26T18:30:58","modified_gmt":"2026-02-26T21:30:58","slug":"from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam","status":"publish","type":"post","link":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/","title":{"rendered":"Opinion: The New Healthtech Thesis in LatAm"},"content":{"rendered":"<p><audio class=\"audio-for-speech\"><\/audio><\/p>\n<div class=\"translate-tooltip-mtz blue sm-root translate hidden_translate\">\n<div class=\"header-wrapper\">\n<div class=\"header-controls\"><\/div>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<div class=\"translate-tooltip-mtz blue sm-root translate hidden_translate\">\n<div class=\"header-wrapper\">\n<div class=\"header-controls\"><\/div>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<h3><img fetchpriority=\"high\" decoding=\"async\" class=\"size-large wp-image-6291 alignright\" src=\"https:\/\/confrapar.com.br\/en\/wp-content\/uploads\/sites\/8\/2026\/02\/Design-sem-nome-5-1024x576.jpg\" alt=\"\" width=\"800\" height=\"450\" srcset=\"https:\/\/confrapar.com.br\/en\/wp-content\/uploads\/sites\/8\/2026\/02\/Design-sem-nome-5-1024x576.jpg 1024w, https:\/\/confrapar.com.br\/en\/wp-content\/uploads\/sites\/8\/2026\/02\/Design-sem-nome-5-300x169.jpg 300w, https:\/\/confrapar.com.br\/en\/wp-content\/uploads\/sites\/8\/2026\/02\/Design-sem-nome-5-768x432.jpg 768w, https:\/\/confrapar.com.br\/en\/wp-content\/uploads\/sites\/8\/2026\/02\/Design-sem-nome-5.jpg 1366w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><strong>Opinion: The Evolution of the Healthtech Investment Thesis in Latin America<\/strong><\/h3>\n<p data-path-to-node=\"3\">Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in <i data-path-to-node=\"3\" data-index-in-node=\"158\">Help Sa\u00fade<\/i>, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, the great challenge for healthtechs was trying to <b data-path-to-node=\"3\" data-index-in-node=\"313\">optimize scarcity<\/b>: our effort was focused on digitalizing schedules and connecting patients to an inelastic supply of doctors. We faced low digitalization among professionals, resistance to behavioral change, and, above all, the insurmountable barrier of the cost and availability of human care. We were trapped in the <b data-path-to-node=\"3\" data-index-in-node=\"632\">fee-for-service<\/b> model, which rewards illness and limits growth to the professional&#8217;s physical time.<\/p>\n<p data-path-to-node=\"4\">Today, the paradigm has shifted, and the investment thesis is radically different thanks to <b data-path-to-node=\"4\" data-index-in-node=\"92\">Artificial Intelligence<\/b>. AI no longer acts merely as a scheduling facilitator but as an <b data-path-to-node=\"4\" data-index-in-node=\"180\">engine for capacity expansion<\/b>. By taking over the &#8220;information layer&#8221; of care\u2014which involves triage, pre-diagnostics, chronic monitoring, and health education\u2014technology reduces the marginal cost to near zero. This allows us, for the first time, to design solutions that meet an unlimited demand for health and well-being.<\/p>\n<p data-path-to-node=\"5\">Latin America has a unique opportunity to <b data-path-to-node=\"5\" data-index-in-node=\"42\">leapfrog<\/b> in this new scenario. Instead of trying to fix or replicate Western models based on resource scarcity and high costs, the region can rapidly adopt new business models that promote the abundant consumption of AI services. The key to this shift is moving away from per-procedure billing in favor of <b data-path-to-node=\"5\" data-index-in-node=\"348\">continuous access<\/b>. Subscription models or Per Member Per Month (PMPM) payments align the incentives of the provider, the startup, and the patient toward long-term preventive health.<\/p>\n<p data-path-to-node=\"6\">However, if yesterday\u2019s barrier was technological adoption, today\u2019s major obstacle is <b data-path-to-node=\"6\" data-index-in-node=\"86\">regulatory<\/b>. The slow adaptation of industry rules could become the primary anchor holding back this revolution. The lack of clear guidelines and specific billing codes for AI-mediated care and services inhibits innovation, preventing these models from achieving scale and financial viability. Maintaining outdated regulations means delaying the safe integration of AI into clinical routines, depriving the population of massive gains in quality of life, reduction of avoidable expenses, and increased productivity.<\/p>\n<p data-path-to-node=\"7\">The game has changed: the challenge is no longer connecting the patient to the doctor, but rather <b data-path-to-node=\"7\" data-index-in-node=\"98\">democratizing continuous care<\/b>. The winners in this new era in LatAm will be the founders and investors capable of pricing abundance and aligning technology with new business models while helping to untie the continent&#8217;s regulatory knots.<\/p>\n<p data-path-to-node=\"7\"><strong>Written by: Kadu Guillaume \/ Founder and Managing Partner at Confrapar S\/A<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":6290,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"class_list":["post-6289","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticia"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then,\" \/>\n\t<meta name=\"robots\" content=\"noindex, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n\t<meta name=\"author\" content=\"Comunica\u00e7\u00e3o\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Confrapar En\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Opinion: The New Healthtech Thesis in LatAm - Confrapar En\" \/>\n\t\t<meta property=\"og:description\" content=\"Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then,\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-02-26T20:51:22+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-02-26T21:30:58+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Opinion: The New Healthtech Thesis in LatAm - Confrapar En\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then,\" \/>\n\t\t<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t\t<meta name=\"twitter:data1\" content=\"Comunica\u00e7\u00e3o\" \/>\n\t\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#blogposting\",\"name\":\"Opinion: The New Healthtech Thesis in LatAm - Confrapar En\",\"headline\":\"Opinion: The New Healthtech Thesis in LatAm\",\"author\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/author\\\/comunicacao\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2026\\\/02\\\/Site-foto-6.png\",\"width\":960,\"height\":1280},\"datePublished\":\"2026-02-26T17:51:22-03:00\",\"dateModified\":\"2026-02-26T18:30:58-03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#webpage\"},\"articleSection\":\"News\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en#listItem\",\"position\":1,\"name\":\"In\\u00edcio\",\"item\":\"https:\\\/\\\/confrapar.com.br\\\/en\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/category\\\/noticia\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/category\\\/noticia\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/category\\\/noticia\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#listItem\",\"name\":\"Opinion: The New Healthtech Thesis in LatAm\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en#listItem\",\"name\":\"In\\u00edcio\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#listItem\",\"position\":3,\"name\":\"Opinion: The New Healthtech Thesis in LatAm\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/category\\\/noticia\\\/#listItem\",\"name\":\"News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/#organization\",\"name\":\"Confrapar\",\"description\":\"We invest in companies that use technology to impact essential sectors. We look for companies from Latin America with high margins, proven and scalable business models, with the potential to grow and enter new markets.\",\"url\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/\",\"telephone\":\"+551127698872\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Logos_Confrapar_01-Logo_Confrapar_Preferencial.png\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/confrapar\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/author\\\/comunicacao\\\/#author\",\"url\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/author\\\/comunicacao\\\/\",\"name\":\"Comunica\\u00e7\\u00e3o\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#webpage\",\"url\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/\",\"name\":\"Opinion: The New Healthtech Thesis in LatAm - Confrapar En\",\"description\":\"Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\\u2019s experience with our investment in Help Sa\\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\\u2019s experience with our investment in Help Sa\\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then,\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/author\\\/comunicacao\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/author\\\/comunicacao\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2026\\\/02\\\/Site-foto-6.png\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#mainImage\",\"width\":960,\"height\":1280},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/news\\\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\\\/#mainImage\"},\"datePublished\":\"2026-02-26T17:51:22-03:00\",\"dateModified\":\"2026-02-26T18:30:58-03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/\",\"name\":\"Confrapar\",\"description\":\"We invest in companies that use technology to impact essential sectors. We look for companies from Latin America with high margins, proven and scalable business models, with the potential to grow and enter new markets.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/confrapar.com.br\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Opinion: The New Healthtech Thesis in LatAm - Confrapar En","description":"Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then,","canonical_url":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/","robots":"noindex, max-snippet:-1, max-image-preview:large, max-video-preview:-1","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#blogposting","name":"Opinion: The New Healthtech Thesis in LatAm - Confrapar En","headline":"Opinion: The New Healthtech Thesis in LatAm","author":{"@id":"https:\/\/confrapar.com.br\/en\/news\/author\/comunicacao\/#author"},"publisher":{"@id":"https:\/\/confrapar.com.br\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/confrapar.com.br\/en\/wp-content\/uploads\/sites\/8\/2026\/02\/Site-foto-6.png","width":960,"height":1280},"datePublished":"2026-02-26T17:51:22-03:00","dateModified":"2026-02-26T18:30:58-03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#webpage"},"isPartOf":{"@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#webpage"},"articleSection":"News"},{"@type":"BreadcrumbList","@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/confrapar.com.br\/en#listItem","position":1,"name":"In\u00edcio","item":"https:\/\/confrapar.com.br\/en","nextItem":{"@type":"ListItem","@id":"https:\/\/confrapar.com.br\/en\/news\/category\/noticia\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/confrapar.com.br\/en\/news\/category\/noticia\/#listItem","position":2,"name":"News","item":"https:\/\/confrapar.com.br\/en\/news\/category\/noticia\/","nextItem":{"@type":"ListItem","@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#listItem","name":"Opinion: The New Healthtech Thesis in LatAm"},"previousItem":{"@type":"ListItem","@id":"https:\/\/confrapar.com.br\/en#listItem","name":"In\u00edcio"}},{"@type":"ListItem","@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#listItem","position":3,"name":"Opinion: The New Healthtech Thesis in LatAm","previousItem":{"@type":"ListItem","@id":"https:\/\/confrapar.com.br\/en\/news\/category\/noticia\/#listItem","name":"News"}}]},{"@type":"Organization","@id":"https:\/\/confrapar.com.br\/en\/#organization","name":"Confrapar","description":"We invest in companies that use technology to impact essential sectors. We look for companies from Latin America with high margins, proven and scalable business models, with the potential to grow and enter new markets.","url":"https:\/\/confrapar.com.br\/en\/","telephone":"+551127698872","logo":{"@type":"ImageObject","url":"https:\/\/confrapar.com.br\/en\/wp-content\/uploads\/2023\/11\/Logos_Confrapar_01-Logo_Confrapar_Preferencial.png","@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#organizationLogo"},"image":{"@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#organizationLogo"},"sameAs":["https:\/\/www.linkedin.com\/company\/confrapar\/"]},{"@type":"Person","@id":"https:\/\/confrapar.com.br\/en\/news\/author\/comunicacao\/#author","url":"https:\/\/confrapar.com.br\/en\/news\/author\/comunicacao\/","name":"Comunica\u00e7\u00e3o"},{"@type":"WebPage","@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#webpage","url":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/","name":"Opinion: The New Healthtech Thesis in LatAm - Confrapar En","description":"Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then,","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/confrapar.com.br\/en\/#website"},"breadcrumb":{"@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#breadcrumblist"},"author":{"@id":"https:\/\/confrapar.com.br\/en\/news\/author\/comunicacao\/#author"},"creator":{"@id":"https:\/\/confrapar.com.br\/en\/news\/author\/comunicacao\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/confrapar.com.br\/en\/wp-content\/uploads\/sites\/8\/2026\/02\/Site-foto-6.png","@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#mainImage","width":960,"height":1280},"primaryImageOfPage":{"@id":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/#mainImage"},"datePublished":"2026-02-26T17:51:22-03:00","dateModified":"2026-02-26T18:30:58-03:00"},{"@type":"WebSite","@id":"https:\/\/confrapar.com.br\/en\/#website","url":"https:\/\/confrapar.com.br\/en\/","name":"Confrapar","description":"We invest in companies that use technology to impact essential sectors. We look for companies from Latin America with high margins, proven and scalable business models, with the potential to grow and enter new markets.","inLanguage":"en-US","publisher":{"@id":"https:\/\/confrapar.com.br\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Confrapar En","og:type":"article","og:title":"Opinion: The New Healthtech Thesis in LatAm - Confrapar En","og:description":"Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then,","og:url":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/","article:published_time":"2026-02-26T20:51:22+00:00","article:modified_time":"2026-02-26T21:30:58+00:00","twitter:card":"summary_large_image","twitter:title":"Opinion: The New Healthtech Thesis in LatAm - Confrapar En","twitter:description":"Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then, Opinion: The Evolution of the Healthtech Investment Thesis in Latin America Our journey as health technology investors has taught us valuable and often tough lessons. In the past, through Confrapar\u2019s experience with our investment in Help Sa\u00fade, we saw firsthand how difficult it was to innovate in a structurally rigid sector. Back then,","twitter:label1":"Written by","twitter:data1":"Comunica\u00e7\u00e3o","twitter:label2":"Est. reading time","twitter:data2":"2 minutes"},"aioseo_meta_data":{"post_id":"6289","title":null,"description":"#post_excerpt #post_content","keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-02-26 20:51:23","updated":"2026-02-26 21:43:47","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/confrapar.com.br\/en\" title=\"In\u00edcio\">In\u00edcio<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/confrapar.com.br\/en\/news\/category\/noticia\/\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tOpinion: The New Healthtech Thesis in LatAm\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"In\u00edcio","link":"https:\/\/confrapar.com.br\/en"},{"label":"News","link":"https:\/\/confrapar.com.br\/en\/news\/category\/noticia\/"},{"label":"Opinion: The New Healthtech Thesis in LatAm","link":"https:\/\/confrapar.com.br\/en\/news\/from-scarcity-to-abundance-the-new-healthtech-thesis-in-latam\/"}],"_links":{"self":[{"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/posts\/6289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/comments?post=6289"}],"version-history":[{"count":5,"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/posts\/6289\/revisions"}],"predecessor-version":[{"id":6299,"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/posts\/6289\/revisions\/6299"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/media\/6290"}],"wp:attachment":[{"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/media?parent=6289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/confrapar.com.br\/en\/wp-json\/wp\/v2\/categories?post=6289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}